English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
2 天
靶向 EZH2:杜氏肌营养不良症治疗新曙光
目前,虽然基因编辑疗法为 DMD 的治疗带来了一丝希望,但临床应用的道路上仍布满荆棘,比如难以确定临床疗效、无法有效控制潜在的脱靶效应等。而糖皮质激素(如地夫可特、泼尼松)虽能延缓疾病进展,却也伴随着肥胖、行为改变、身材矮小和骨质减少等诸多副作用,就像 “饮鸩止渴”,让患者陷入两难境地。因此,寻找更安全有效的治疗方法,成为了医学领域亟待攻克的难题。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Return to Earth
Agrees to limited ceasefire
Trump revokes protection
US housing starts rebound
Removing privacy setting
Corruption trial begins
Patient dies post-therapy
Peru declares emergency
Reinstating fired workers
Worker stole $1.6 million
'Sunrise on the Reaping'
Plea to halt execution denied
Morgan says he’s OK
Judge on USAID shutdown
Free checked bag promotion
WH says US won't return
ISR conducts strikes in Gaza
Texas measles cases rise
Siemens to cut jobs
Bryan Bedford to lead FAA
Earthquake shakes Bay Area
DOGE gains access to USIP?
Lebanon-Syria ceasefire
Tapped as top bank cop
Honduras plane crash
JFK files to be released
Delta plane wing hits runway
Parents on missing daughter
On judicial impeachment call
'Get Together' singer dies
反馈